Insiders · Profile

Wolff Stefani

EVP and COO at Nurix Therapeutics. Filing since 2 May 2022. CIK 0001751790

Company
Date
Role
Action
Shares
Amount
Of holding
1 May 2023
EVP and COO
Sold at will
342
$3.38K
5.3%
30 Jan 2023
EVP and COO
Sold, plan not stated
424
$4.99K
9.7%
31 Oct 2022
EVP and COO
Sold, plan not stated
350
$4.51K
9.3%
1 Aug 2022
EVP and COO
Sold, plan not stated
356
$5.58K
22.3%
2 May 2022
EVP and COO
Sold, plan not stated
330
$3.88K
34.3%
5 decisions on file.